Interviews

Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what the implementation of the recent unanimous SCOTUS ruling on Rutledge v. PCMA may look like.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what proper screening and protection looks like for health care workers administering the COVID-19 vaccine looks like.

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers about the effect of coronavirus disease 2019 (COVID-19) on cancer clinical trials.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the COVID-19 vaccine.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the role of independent pharmacies in the country during the COVID-19 pandemic.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent SCOTUS ruling on Rutledge v. PCMA may help independent community pharmacies rebuild what may have been lost due to low reimbursement rates.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent unanimous SCOTUS ruling on Rutledge v. PCMA will impact independent pharmacies across the country.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the COVID-19 pandemic has reinforced pharmacists’ purpose of championing the health of every community.

Pharmacy Times® interviewed Thomas D’Angelo, RPh, president of the Pharmacists Society of the State of New York, on how independent pharmacies may be well-positioned to assist in the administration of COVID-19 vaccines.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how the hours of operation of pharmacies involved in the COVID-19 vaccinations have been impacted by vaccination efforts.

Pharmacy Times® interviewed Emily Cook, a partner with McDermott Will & Emery, on the release of the final 340B Administrative Dispute Resolution (ADR) Rule and what it may mean for pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on how COVID-19 vaccinations has affected the day-to-day of pharmacies.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.

Pharmacy Times® interviewed Chad Landmon, the chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the potential impact President-elect Joseph Biden’s cabinet nominations may have on the pharmacy field in 2021.

Although safety and efficacy have been proven, a few questions still remain about how long the vaccines will be effective and whether they prevent asymptomatic infection.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the rollout of phase 1b and c of COVID-19 vaccinations at Walgreens pharmacies.

One of the main challenges with the distribution process is that each state has its own jurisdictional plan, which can create some confusion.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.

Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a letter that was signed by President-elect Biden’s pick for HHS secretary to the outgoing HHS secretary on the enforcement of 340B drug pricing laws.

In a recent interview with Pharmacy Times, Barbara Giacomelli, BS Pharm, PharmD, discussed the trends she hopes to see in the pharmacy field in 2021 and where she sees the landscape changing.

Patrick Campbell, PharmD, PhD, the senior director of research at the Pharmacy Quality Alliance, discusses why sending a short video to a patient’s phone can improve primary medication adherence and why it’s more effective than text messages.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on how pharmacies and their patients are affected by issues regarding the regulation of the sale of 340B discounted drugs.

Having a shared cultural understanding allows the pharmacy to make medical and educational interventions relevant to the patient and allows patients to actively participate in their care.

Pharmacy Times® interviewed William von Oehsen, JD, principal at Powers Pyles Sutter & Verville, on a lawsuit filed against the HHS and HRSA regarding the sale of 340B discounted drugs.

Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.